LPCN
Lipocine Inc.$1.67-0.04 (-2.34%)Prev Close$1.71·MCap$11.9M·P/E—·Vol116.2K·Yield—
▲
Buys (12M)
6
$545.8K
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$545.8K
●
Active Insiders
2
last 12 mo
Over the past 12 months, insider activity at Lipocine Inc. (LPCN) has been exclusively buying, with 6 insider purchases totaling $545.8K and 0 insider sales totaling $0.00. The most recent insider transaction was by Patel Mahesh V. (director, officer: Chief Executive Officer), who purchased $79.5K worth of shares on Nov 13, 2026. Lipocine Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $11.9M.
LPCN Insider Trading Activity
LPCN Insider Buying Activity
The following table shows recent insider purchases of Lipocine Inc. (LPCN) stock reported via SEC Form 4 filings.
LPCN Insider Selling Activity
The following table shows recent insider sales of Lipocine Inc. (LPCN) stock reported via SEC Form 4 filings.
No insider selling activity found for LPCN in the last 12 months.